^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CMAB 819 (nivolumab biosimilar)

    i
    Other names: CMAB 819
    Associations
    News
    Trials
    Company:
    Mabpharm Limited
    Drug class:
    PD1 inhibitor
    Related drugs:
    Associations
    News
    Trials